NeoCura is a high-tech enterprise that relies on AI technology to create an RNA technology platform and conduct R&D of innovative drugs. The company has built multi-omics big data acquisition platforms and multiple bioomics databases. It uses AI and bioinformatics technology to conduct in-depth drug target mining and fully automated drug design for innovative RNA technology platform upgrades and drug research. It has established leading R&D centers and production centers in Beijing, Shenzhen, and Guangzhou to support pipelines development, platform upgrades, and clinical demand.
AI empowers RNA throughout the entire flow process, accelerating research and development of drugs and technology upgrades
A top-notch complementarity team, bringing together top experts from tumor immunology, RNA delivery, molecular engineering, artificial intelligence, and industrialization fields
Gather strength by integrating top resources in research, industry, and clinical fields at home and abroad to break through obstacles
More than 10 First-in-Class R&D pipelines focusing on cancer vaccines , tumor immunomodulator, and virus vaccines
